1. Home
  2. NATH vs AVXL Comparison

NATH vs AVXL Comparison

Compare NATH & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nathan's Famous Inc.

NATH

Nathan's Famous Inc.

N/A

Current Price

$95.22

Market Cap

397.6M

ML Signal

N/A

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

HOLD

Current Price

$4.01

Market Cap

397.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NATH
AVXL
Founded
1916
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Restaurants
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
397.6M
397.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
NATH
AVXL
Price
$95.22
$4.01
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$22.00
AVG Volume (30 Days)
50.8K
4.1M
Earning Date
11-06-2025
11-25-2025
Dividend Yield
2.10%
N/A
EPS Growth
4.02
N/A
EPS
5.56
N/A
Revenue
$154,991,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$17.13
N/A
Revenue Growth
7.82
N/A
52 Week Low
$75.15
$2.86
52 Week High
$118.50
$14.44

Technical Indicators

Market Signals
Indicator
NATH
AVXL
Relative Strength Index (RSI) 47.62 36.99
Support Level $88.67 $3.96
Resistance Level $97.34 $4.88
Average True Range (ATR) 3.30 0.41
MACD 0.76 0.20
Stochastic Oscillator 71.64 55.44

Price Performance

Historical Comparison
NATH
AVXL

About NATH Nathan's Famous Inc.

Nathan's Famous Inc is an owner of fast food franchises in the United States. The company's reportable segment includes the Branded Product Program, Product licensing, Restaurant operations and Corporate. Branded Product Program derives revenue principally from the sale of hot dog products either directly to foodservice operators or to various foodservice distributors who resell the products to foodservice operators. It generates maximum revenue from the Branded Product Program segment. Geographically, it derives a majority of revenue from the United States.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Share on Social Networks: